January 3, 2011 — Ritedose is voluntarily recalling 0.083% albuterol sulfate inhalation solution in 3-mL single-use dose vials because some vials are embossed with incorrect concentration information, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

New Delhi, Apr 23 (PTI) Pharma major Cipla Ltd on Thursday said it has received final approval from the US health regulator for its generic version of albuterol sulfate inhalation aerosol indicated ...

Purpose: The effects of extreme temperatures on drug delivery of two albuterol sulfate hydrofluoroalkane, metered-dose inhalers (MDIs) were evaluated.Methods. Three Proventil HFA and three Ventolin ...

A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...

Albuterol (as sulfate) 0.63mg/3mL (0.021%), 1.25mg/3mL (0.042%); preservative-free. Avoid excessive use. Sensitivity to sympathomimetics. Consider higher dose albuterol product in acute attack.

Albuterol 90mcg/inh; metered-dose aerosol. <4yrs: not recommended. ≥4yrs: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise–induced bronchospasm: 2 inh 15 minutes before exercise.

FDA announced in a June 4, 2021 release that it had approved an abbreviated new drug application submitted by Sandoz for albuterol sulfate inhalation aerosol 90 mcg (base)/actuation in a metered dose ...

Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 /PRNewswire/ - ...

In this Oct. 14, 2020, file photo, a woman who has an asthma disorder holds a box of inhalation solution of Ipratropium Bromide and Albuterol Sulfate, prescribed medication at her home in Keizer, Ore.

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...